See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $466B | 7.7x | 18.1x | |
| $359B | 4.2x | 15.1x | |
| $234B | 4.5x | 18.9x | |
| $168B | 2.5x | 11.5x | |
| $79.2B | 1.5x | 7.1x | |
| $71.6B | 3.5x | 14.6x | |
| $65.1B | 3.4x | 12.4x | |
| $58.8B | 8.2x | 35.8x | |
| $54.6B | 3.7x | 14.7x | |
| $50.7B | 9.9x | 42.9x | |
| $46.0B | 3.1x | 21.6x | |
| $41.9B | 4.5x | 18.3x | |
| $40.6B | 2.7x | 12.1x | |
| $33.6B | 1.4x | 7.6x | |
| $29.2B | 2.4x | 16.0x | |
| $22.5B | 1.5x | 8.1x | |
| $22.4B | 2.2x | 6.2x | |
| $22.4B | 3.6x | 15.9x | |
| $21.4B | 1.8x | 10.6x | |
| $18.1B | 1.7x | 11.1x | |
| $13.7B | 8.1x | 39.4x | |
| $12.4B | 2.1x | 14.2x | |
| $11.2B | 1.9x | 9.4x | |
| $10.7B | 7.0x | 27.8x | |
| $10.4B | 7.4x | 41.3x | |
| $9.3B | 6.4x | 34.3x | |
| $8.1B | 1.3x | 7.5x | |
| $7.6B | 1.2x | 13.8x | |
| $6.8B | 1.2x | 6.6x | |
| $6.2B | 9.2x | 28.8x | |
| $6.0B | 2.8x | 15.9x | |
| $6.0B | 6.2x | 24.0x | |
| $5.4B | 3.6x | 17.8x | |
| $5.1B | 1.2x | 7.0x | |
| $4.7B | 1.7x | 11.0x | |
| $4.6B | 9.4x | 36.8x | |
| $4.6B | 1.6x | 6.7x | |
| $4.4B | 10.5x | 32.0x | |
| $4.3B | 3.6x | 22.3x | |
| $4.2B | 1.3x | 7.2x | |
| $3.9B | 3.5x | 10.7x | |
| $3.7B | 1.2x | 7.3x | |
| $3.7B | 1.7x | 10.6x | |
| $3.6B | 4.1x | 10.3x | |
| $3.3B | 2.1x | 11.4x | |
| $3.0B | 1.5x | 10.4x | |
| $2.8B | 8.6x | 32.1x | |
| $2.7B | 1.9x | 9.2x | |
| $2.7B | 0.6x | 5.2x | |
| $2.6B | 1.0x | 7.8x | |
| $2.6B | 2.5x | 11.0x | |
| $2.4B | 1.0x | 5.2x | |
| $2.4B | 5.6x | 21.3x | |
| $2.4B | 3.0x | 14.8x | |
| $2.4B | 0.7x | 4.8x | |
| $2.2B | 0.5x | 6.4x | |
| $2.1B | 5.7x | 16.4x | |
| $2.0B | 3.6x | 17.7x | |
| $2.0B | 2.6x | 18.3x | |
| $2.0B | 0.9x | 6.6x | |
| $1.9B | 1.8x | 12.5x | |
| $1.8B | 2.7x | 12.7x | |
| $1.7B | 1.1x | 9.1x | |
| $1.6B | 2.2x | 11.0x | |
| $1.6B | 0.9x | 6.8x | |
| $1.6B | 6.0x | 16.8x | |
| $1.6B | 1.4x | -19.2x | |
| $1.5B | 0.7x | 7.8x | |
| $1.4B | 1.1x | 7.6x | |
| $1.4B | 0.8x | 6.3x | |
| $1.3B | 1.8x | 7.4x | |
| $1.3B | 0.6x | 5.6x | |
| $1.1B | 1.5x | 10.1x | |
| $1.0B | 8.0x | 30.0x | |
| $954M | 2.3x | 10.3x | |
| $932M | 3.8x | 54.7x | |
| $914M | 0.8x | 7.6x | |
| $792M | 1.7x | 8.3x | |
| $787M | 1.0x | 5.2x | |
| $727M | n/a | n/a | |
| $661M | n/a | n/a | |
| $647M | 0.2x | 1.5x | |
| $602M | n/a | n/a | |
| $596M | 0.8x | 6.8x | |
| $562M | 1.3x | 8.1x | |
| $553M | 1.9x | -26.7x | |
| $527M | 0.4x | n/a | |
| $517M | n/a | n/a | |
| $511M | n/a | n/a | |
| $451M | 2.2x | -47.7x | |
| $420M | 1.5x | 18.8x | |
| $348M | 0.8x | 10.0x | |
| $346M | 1.2x | 9.4x | |
| $334M | 1.4x | n/a | |
| $320M | n/a | n/a | |
| $305M | n/a | n/a | |
| $246M | 0.7x | 11.1x | |
| $232M | 4.6x | 17.4x | |
| $223M | n/a | n/a | |
| $204M | 0.4x | 11.9x | |
| $197M | 2.4x | 13.9x | |
| $196M | 1.4x | 6.0x | |
| $189M | 1.0x | 9.3x | |
| $178M | 0.9x | 3.9x | |
| $159M | 0.8x | 5.7x | |
| $152M | n/a | n/a | |
| $149M | 0.6x | 6.1x | |
| $143M | n/a | n/a | |
| $135M | 2.2x | 8.0x | |
| $127M | 0.5x | 5.8x | |
| $79.4M | n/a | n/a | |
| $67.0M | 0.3x | 6.9x | |
| $59.9M | 2.3x | 9.6x | |
| $46.0M | n/a | n/a | |
| $42.3M | n/a | n/a | |
| $39.2M | n/a | n/a | |
| $30.9M | 0.7x | n/a | |
| $30.9M | n/a | n/a | |
| $28.6M | 2.3x | n/a | |
| $26.5M | n/a | n/a | |
| $25.4M | 1.3x | -14.9x | |
| $20.8M | n/a | n/a | |
| $18.0M | n/a | n/a | |
| $17.2M | n/a | n/a | |
| $13.4M | n/a | n/a | |
| $6.7M | n/a | n/a | |
| $5.4M | n/a | n/a | |
| $0.8M | n/a | n/a | |
| -$38.7M | -0.1x | -26.4x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty